However, the lack of transparency, reproducibility, and customisation of LLMs remains a challenge that restricts their widespread use in biomedical research. For biomedical researchers ...
Hosted on MSN1mon
Boltz-1 AI: MIT’s open-source model speeds up drug discovery, biomedical researchIn a significant breakthrough for biomedical research and drug development, scientists at the Massachusetts Institute of Technology (MIT) have introduced an innovative open-source AI model named ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results